RT Journal Article
SR Electronic
T1 A computational optimization approach for the automatic generation of Gamma Knife radiosurgery treatment plans
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.26.21262676
DO 10.1101/2021.08.26.21262676
A1 Walker, Matthew R.
A1 Malekmohammadi, Mehrdad
A1 Coolens, Catherine
A1 Laperriere, Normand
A1 Heaton, Robert
A1 Sheikholeslami, Ali
A1 Hodaie, Mojgan
YR 2021
UL http://medrxiv.org/content/early/2021/08/28/2021.08.26.21262676.abstract
AB Gamma Knife (GK) radiosurgery is a non-invasive treatment modality which allows single fraction delivery of focused radiation to one or more brain targets. Treatment planning mostly involves manual placement and shaping of shots to conform the prescribed dose to a surgical target. This process can be time consuming and labour intensive. An automated method is needed to determine the optimum combination of treatment parameters to decrease planning time and chance for operator-related error. Recent advancements in hardware platforms which employ parallel computational methods with stochastic optimization schemes are well suited to solving such combinatorial optimization problems efficiently. We present a method of generating optimized GK radiosurgery treatment plans using these techniques, which we name ROCKET (Radiosurgical Optimization Configuration Kit for Enhanced Treatments). Our approach consists of two phases in which shot isocenter positions are generated based on target geometry, followed by optimization of sector collimator parameters. Using this method, complex treatment plans can be generated, on average, in less than one minute, a substantial decrease relative to manual planning. Our results also demonstrate improved selectivity and treatment safety through decreased exposure to nearby organs-at-risk (OARs), compared to manual reference plans with matched coverage. Stochastic optimization is therefore shown to be a robust and efficient clinical tool for the automatic generation of GK radiosurgery treatment plans.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFinancial support for this work was provided to authors Walker, Malekmohammadi, Sheikholeslami, and Hodaie by Fujitsu Limited and Fujitsu Consulting (Canada) Inc.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval for this study was provided by the Research Ethics Board at the University Health Network, Toronto, Ontario, Canada.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request. Please contact corresponding author.